Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus vs Continuous Terlipressin in Acute Variceal Bleeding
NCT02695862Phase 4Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of terlipressin in esophageal varices (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Reduction of Hepatic Venous Pressure Gradient >10% at 24 hours. Started May 2016; status: completed.
02
Drugs
terlipressin
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT02695862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695862.